Last reviewed · How we verify
NCT07066046
Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
NA trial testing Colonoscopy in Colorectal Cancer (CRC) in 1,000 participants. Currently enrolling.
1 February 2026
Quick facts
| Lead sponsor | Instituto do Cancer do Estado de São Paulo |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 1,000 |
| Start date | 1 February 2025 |
| Primary completion | 1 February 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Colonoscopy
Conditions studied
- Colorectal Cancer (CRC) — all drugs for Colorectal Cancer (CRC) →
- Adenomatous Polyposis — all drugs for Adenomatous Polyposis →
- Colorectal Lesions — all drugs for Colorectal Lesions →
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
Instituto do Cancer do Estado de São Paulo — full company profile →
Who can join
18 and older, any sex, with Colorectal Cancer (CRC) or Adenomatous Polyposis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to evaluate the effectiveness of artificial intelligence-assisted colonoscopy in increasing adenoma detection rate and the accuracy in the characterization of colorectal lesions, compared to standard colonoscopy, in a randomized controlled clinical trial setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07066046
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Colonoscopy
Trials testing the same drug.
- NCT07361575 — Study Comparing the Quality of Colon Cleanliness With Prepackaged LRD (Low-residue Diet) vs. Guided (POG). · NA · not yet recruiting
- NCT06983639 — Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance · NA · recruiting
- NCT05630794 — Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 · Phase 1 · recruiting
- NCT07140679 — Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or · Phase 2 · recruiting
- NCT07503847 — Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49 · NA · enrolling by invitation
Other recruiting trials for Colorectal Cancer (CRC)
Currently open trials in the same condition.
- NCT07448142 — Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer · Phase 2 · recruiting
- NCT07223047 — A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agent · Phase 1, PHASE2 · recruiting
- NCT07106892 — Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects Wit · Phase 2 · recruiting
- NCT07152210 — Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced C · NA · recruiting
- NCT07046468 — Smart Pill for Measuring Gut Health in Colon Inflammation and Colon Cancer · recruiting
Other Instituto do Cancer do Estado de São Paulo trials
Trials by the same sponsor.
- NCT06887621 — Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk f · Phase 2 · recruiting
- NCT06282354 — Telemedicine for Postoperative Follow-up After Oncological Surgeries · unknown
- NCT05622136 — Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma · Phase 2 · active not recruiting
- NCT05996367 — Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma · NA · recruiting
- NCT06070376 — Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07066046 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto do Cancer do Estado de São Paulo
- Last refreshed: 16 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07066046.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing